Literature DB >> 1379372

Current role of laser and photodynamic therapy in gastrointestinal tumors and analysis of a 10-year experience.

P Spinelli1, M Dal Fante, A Mancini.   

Abstract

Laser energy can be used for a variety of neoplastic diseases including benign tumors, early stage malignancies, and advanced carcinomas, either with curative intent or for palliation. Nd:YAG laser photocoagulation of 168 colorectal adenomas allowed a complete eradication in 70% of cases, after a mean follow-up of 22 months. Advanced and obstructing tumors were treated with Nd:YAG laser to recanalize the lumen. In the upper gastrointestinal tract the recanalization of the lumen by means of laser photocoagulation improved the quality of life and survival. In fact, in our series of 308 patients treated, 1-year survival was 23% in recanalized patients and 7% in nonrecanalized patients. In the lower gastrointestinal tract, 289 cancer patients were treated and an amelioration of symptoms related to the obstruction was obtained in 93%. The current indication for photodynamic therapy is mainly the treatment of flat or ulcerative early stage tumors in the esophagus and stomach of high risk patients. Out of 17 patients treated, 14 were locally cured.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379372     DOI: 10.1002/ssu.2980080405

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  3 in total

1.  Differences in the sensitivity of ovarian cancer to photodynamic therapy and the mechanisms for those differences.

Authors:  Yoshihito Yokoyama; Tatsuhiko Shigeto; Rie Miura; Asami Kobayashi; Makito Mizunuma; Aisa Yamauchi; Masayuki Futagami; Hideki Mizunuma
Journal:  Oncol Lett       Date:  2017-04-25       Impact factor: 2.967

Review 2.  Current concepts in gastrointestinal photodynamic therapy.

Authors:  J Webber; M Herman; D Kessel; D Fromm
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

Review 3.  Esophageal cancer, early disease: diagnosis and current treatment.

Authors:  H D Becker
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.